Your browser doesn't support javascript.
loading
Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation.
Taranto, Eleanor; Redd, Robert; Jeter, Erin; McHugh, Kristin; Crombie, Jennifer L; Fisher, David C; Jacobsen, Eric; Jacobson, Caron A; Kim, Austin I; LaCasce, Ann S; Odejide, Oreofe O; Dahi, Parastoo B; Nieto, Yago; Joyce, Robin M; Chen, Yi-Bin; Bonjoc, Kimberley-Jane C; Chaudhry, Ammar; Herrera, Alex F; Armand, Philippe; Merryman, Reid W.
Afiliación
  • Taranto E; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Redd R; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Jeter E; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
  • McHugh K; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Crombie JL; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Fisher DC; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Jacobsen E; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Jacobson CA; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kim AI; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
  • LaCasce AS; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Odejide OO; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Dahi PB; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Nieto Y; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Joyce RM; Department of Hematologic Malignancy, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Chen YB; Hematopoietic Cell Therapy and Transplant Program, Massachusetts General Hospital, Boston, MA, USA.
  • Bonjoc KC; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA.
  • Chaudhry A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA.
  • Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA.
  • Armand P; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Merryman RW; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
Leuk Lymphoma ; 63(12): 2912-2917, 2022 12.
Article en En | MEDLINE | ID: mdl-35938581
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos